"目录号: HY-13687
IKK 16 是一种选择性的 IκB 激酶 (IKK) 抑制剂，作用于IKK-2，IKK complex和IKK-1，IC50分别为 40 nM，70 nM 和 200 nM。
相关产品
Resveratrol-MLN120B-MRT67307-TPCA-1-Amlexanox-BMS-345541-BI605906-ACHP Hydrochloride-Apigenin-Icariin-SC-514-IMD-0354-AZD3264-IKK epsilon-IN-1-LY2409881-
生物活性
Description
IKK 16 is a selective IκB kinase (IKK) inhibitor forIKK-2,IKK complexandIKK-1withIC50s of 40 nM, 70 nM and 200 nM, respectively.
IC50& Target
IC50: 40 nM (IKK-2), 70 nM (IKK complex), 200 nM (IKK-1)[1]
In Vitro
IKK 16 is a potent inhibitor of IKK2 with IC50value of 40 nM[1]. IKK 16 increases the expression of Nrf2 but it has no effect on TGF-β1-induced endothelial-mesenchymal transition (EndMT). IKK-16 has the ability to enhance the expression of IκBα and Nrf2. IKK 16 (10 μmol/mL) has the ability to enhance the expression of IκBα and Nrf2 but it has no effect on Smad7 expression. In addition, the AT-RvD1 can also enhance the expression of IκBα[2].
In Vivo
IKK 16 also demonstrates significant in vivo activity in an acute model of cytokine release. Both routes of administration of IKK 16 (30 mg/kg, sc) or orally (30 mg/kg, p.o) at the indicated dose results in a significant inhibition of 86% (sc) and 75% (p.o.).IKK 16(10 mg/kg, sc) is also active in the thioglycollate-induced peritonitis model in the mouse. The maximal inhibition of neutrophil extravasation in this model is about 50%[1]. Treatment of septic mice with IKK 16 (1 mg/kg body weight i.v.) results in a significantly increased degree of phosphorylation (P<0.05) of serine residues on Akt and eNOS in the liver[3].
References
